Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Dermatologic 1

Conditions

Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 4Thymoma 2Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Radiation Pneumonitis 1Pneumonia 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Myasthenia Gravis 1Melanoma 1Lung Diseases, Interstitial 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colitis 1Carcinoma, Renal Cell 1Advanced Squamous Non Small Cell Lung Cancer 1Adenocarcinoma 1

Interventions

vedolizumab 2LDP-02 2Infliximab 2Immunoglobulin G 2Fecal Microbiota Transplantation 2Disulfides 2CT-P13 2prednylidene 1deltacortene 1Standard of Care 1Prednisone 1Practice Guidelines as Topic 1Loperamide 1Endoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colitis × Prednisone × Thoracic × Clear all
NCT03819296 2026-03-11

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

M.D. Anderson Cancer Center

Phase 1 Recruiting
800 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Colitis, Lung Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡